Back to search

Article

Acitretin mitigates uroporphyrin-induced bone defects in congenital erythropoietic porphyria models

2021-03-30

Abstract excerpt

<h4>ABSTRACT</h4> Congenital erythropoietic porphyria (CEP) is a rare genetic disorder leading to accumulation of uro/coproporphyrin-I in tissues due to inhibition of uroporphyrinogen-III synthase. Clinical manifestations of CEP include bone fragility, severe photosensitivity and photomutilation. Currently there is no specific treatment for CEP, except bone marrow transplantation, and there is an unmet need for t...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
4e63394d-cf08-5fd6-a9e4-32684d2ee1f4
DOI
10.1101/2021.03.30.437658
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Acitretin mitigates uroporphyrin-induced bone defects in congenital erythropoietic porphyria modelsDOI 10.1101/2021.03.30.437658
Select a neighboring publication to make it the new centre.